Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
(Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 21.01%5.78B | 23.44%5.56B | 9.81%4.89B | 10.73%18.49B | 14.84%4.75B | 8.59%4.78B | 9.03%4.51B | 10.55%4.46B | 13.29%16.7B | 5.19%4.14B |
Operating revenue | 21.01%5.78B | 23.44%5.56B | 9.81%4.89B | 10.73%18.49B | 14.84%4.75B | 8.59%4.78B | 9.03%4.51B | 10.55%4.46B | 13.29%16.7B | 5.19%4.14B |
Cost of revenue | 21.46%1.96B | 25.23%1.9B | 10.96%1.63B | 8.66%6.25B | 13.30%1.65B | 14.41%1.61B | 3.70%1.51B | 3.31%1.47B | 6.98%5.75B | 0.55%1.46B |
Gross profit | 20.78%3.82B | 22.53%3.67B | 9.24%3.26B | 11.81%12.24B | 15.68%3.1B | 5.85%3.17B | 11.94%2.99B | 14.49%2.99B | 16.92%10.95B | 7.90%2.68B |
Operating expense | 29.65%1.43B | 39.05%1.44B | 33.23%1.24B | 8.19%4.31B | 18.23%1.23B | 16.60%1.1B | 5.60%1.04B | -7.53%933M | 7.02%3.98B | -0.19%1.04B |
Selling and administrative expenses | 29.65%1.43B | 39.05%1.44B | 33.23%1.24B | 8.26%4.31B | 18.47%1.24B | 16.60%1.1B | 5.60%1.04B | -7.53%933M | 7.01%3.98B | -0.19%1.05B |
-Selling and marketing expense | ---- | 39.05%1.44B | ---- | 12.91%3.24B | ---- | ---- | 5.60%1.04B | ---- | 5.48%2.87B | ---- |
-General and administrative expense | 29.65%1.43B | ---- | 33.23%1.24B | -3.67%1.08B | -9.72%-2B | 16.60%1.1B | ---- | -7.53%933M | 11.16%1.12B | -9.04%-1.82B |
Other operating expenses | ---- | ---- | ---- | -100.00%-6M | ---- | ---- | ---- | ---- | 0.00%-3M | ---- |
Operating profit | 16.04%2.39B | 13.77%2.22B | -1.66%2.02B | 13.88%7.94B | 14.06%1.87B | 0.88%2.06B | 15.62%1.95B | 28.39%2.05B | 23.44%6.97B | 13.77%1.64B |
Net non-operating interest income expense | 25.84%-66M | 2.35%-83M | 1.14%-87M | 0.00%-339M | -6.94%-77M | 15.24%-89M | -1.19%-85M | -12.82%-88M | -34.52%-339M | -14.29%-72M |
Non-operating interest income | 433.33%32M | 85.71%13M | -27.27%8M | -26.53%36M | 140.00%12M | -14.29%6M | -12.50%7M | -63.33%11M | -46.15%49M | -72.22%5M |
Non-operating interest expense | 2.17%94M | 3.33%93M | 0.00%93M | -3.17%366M | 19.40%80M | -15.60%92M | -3.23%90M | 6.90%93M | 12.17%378M | -10.67%67M |
Total other finance cost | 33.33%4M | 50.00%3M | -66.67%2M | -10.00%9M | ---- | 0.00%3M | 300.00%2M | -71.43%6M | 66.67%10M | ---- |
Other net income (expense) | ||||||||||
Special income (charges) | --0 | --0 | --0 | 1,647.37%332M | 68.42%32M | --0 | --0 | --300M | 105.44%19M | 105.44%19M |
-Less:Other special charges | ---- | ---- | ---- | -1,647.37%-332M | ---32M | ---- | ---- | ---300M | -5.56%-19M | ---- |
Income before tax | 17.46%2.33B | 14.64%2.15B | -14.48%1.94B | 19.52%7.94B | 15.80%1.82B | 2.26%1.99B | 16.28%1.87B | 48.72%2.27B | 31.30%6.64B | 51.11%1.57B |
Income tax | 24.38%556M | 21.16%521M | -8.45%444M | -1.88%1.72B | 10.74%361M | -38.00%447M | 21.13%430M | 37.01%485M | 50.73%1.76B | 14.79%326M |
Net income | 15.45%1.78B | 12.70%1.62B | -16.12%1.49B | 27.21%6.22B | 17.12%1.46B | 26.02%1.54B | 14.91%1.44B | 52.40%1.78B | 25.46%4.89B | 64.55%1.24B |
Net income continuous Operations | 15.45%1.78B | 12.70%1.62B | -16.12%1.49B | 27.21%6.22B | 17.12%1.46B | 26.02%1.54B | 14.91%1.44B | 52.27%1.78B | 25.49%4.89B | 64.77%1.24B |
Minority interest income | 0 | 0 | 0 | 0.00%1M | 0 | 0 | 0 | 0 | 1M | 0 |
Net income attributable to the parent company | 15.53%1.78B | 12.70%1.62B | -16.13%1.49B | 27.19%6.22B | 17.03%1.46B | 25.94%1.54B | 15.00%1.44B | 52.31%1.78B | 25.49%4.89B | 64.68%1.25B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 15.53%1.78B | 12.70%1.62B | -16.13%1.49B | 27.19%6.22B | 17.03%1.46B | 25.94%1.54B | 15.00%1.44B | 52.31%1.78B | 25.49%4.89B | 64.68%1.25B |
Basic earnings per share | 18.18%1.17 | 16.30%1.07 | -12.50%0.98 | 30.59%3.97 | 20.51%0.94 | 30.26%0.99 | 17.95%0.92 | 55.99%1.12 | 30.92%3.04 | 68.83%0.78 |
Diluted earnings per share | 18.18%1.17 | 16.30%1.07 | -12.50%0.98 | 30.59%3.97 | 20.51%0.94 | 30.26%0.99 | 17.95%0.92 | 55.99%1.12 | 30.92%3.04 | 68.83%0.78 |
Dividend per share | 0 | -37.84%0.927 | 0 | 18.54%1.4914 | 0 | 0 | 1.4914 | 0 | 17.01%1.2581 | 0 |
Currency Unit | SEK | SEK | SEK | SEK | SEK | SEK | SEK | SEK | SEK | SEK |